Register entry

Taiho Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 human prescription drug. By marketing category: NDA 6.

Dosage formNDCs
tablet, film coated3
tablet2
kit1
RouteNDCs
oral5
Labeller name on the listingNDCs
taiho pharmaceutical co., ltd.3
taiho pharmaceutical co., ltd.3
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
INQOVICEDAZURIDINE and DECITABINEtablet, film coated, oral64842-0727NDA
LONSURFtrifluridine and tipiraciltablet, film coated, oral64842-1020NDA
LONSURFtrifluridine and tipiraciltablet, film coated, oral64842-1025NDA
LYTGOBIFUTIBATINIBtablet, oral64842-0120NDA
LYTGOBIFUTIBATINIBtablet, oral64842-0127NDA
LYTGOBILYTGOBIkit64842-0128NDA
Compare

Other companies listing futibatinib

Enquiry

Common questions

Is Taiho Pharmaceutical Co., Ltd. FDA approved?
Taiho Pharmaceutical Co., Ltd. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Taiho Pharmaceutical Co., Ltd. make?
6 products are listed under Taiho Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as tablet, film coated; tablet; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.